Pharma Commercial Forecasting Expert for AI Evaluation

Provide expert human judgment on commercial drug launches by creating and critiquing evaluation rubrics, building or reviewing launch curves, and assessing the defensibility of commercial forecast assumptions across a set of drug launches. This is a paid pilot engagement with the possibility of recurring work for strong contributors.

• Create and critique rubrics that evaluate commercial drugs and drug development programs.
• Build or critique launch curves, including uptake, peak share, and trajectory.
• Assess whether a commercial forecast''s assumptions, such as choice of analogs, ramp rates, peak share estimates, and loss of exclusivity impacts, are defensible.
• Apply the above analyses across the pilot''s set of drug launches, providing clear, expert reasoning.

• Minimum 5 years of experience in pharma commercial forecasting, analytics, or strategy.
• Proven experience building or critiquing drug launch and uptake models.
• Familiarity with biotech and pharmaceutical development programs.
• Background in US pharma commercial roles, sales teams, forecasting, or commercial strategy is acceptable.

• Engagement type, hourly paid pilot.
• Estimated commitment, approximately 10 to 20 hours total over a 1 to 2 week pilot period.
• Remote work, candidates must be US-based or have deep US-market experience.
• Strong contributors may be invited to participate in recurring or expanded engagements as the work scales.

Paid hourly, range is 130 to 210 hourly for the pilot.

• Candidates must be US-based or demonstrate deep US-market commercial experience.
• Open to professionals from pharma commercial forecasting, analytics, strategy, or sales backgrounds who meet the experience requirements above.